In Blow To Teva, Federal Circuit Refuses To Rehear Zoloft Patent Case

Law360, New York (April 4, 2005, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has refused Israeli drug maker Teva Pharmaceuticals’ request for an en-banc rehearing of its patent case over a generic version of Pfizer Inc.'s antidepressant Zoloft.

In January, the Washington-based appeals court rejected Teva's bid to overturn a lower court ruling over whether the company could seek a court ruling that it did not infringe on Pfizer's brand-name patent before it released its generic version of Zoloft.

Teva had filed an Abbreviated New Drug Application (ANDA) with the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.